Key result
Early post-STEMI functional class ≥2 is linked to ~278% higher 1-year death or HF hospitalization risk.
Why the study?
Does early post-discharge heart failure (NYHA class ≥2) increase the risk of death or hospitalization for heart failure in STEMI patients treated with primary PCI?
Cohort (n=402)
Does early post-discharge heart failure (NYHA class ≥2) increase the risk of death or hospitalization for heart failure in STEMI patients treated with primary PCI?
Early post-discharge heart failure symptoms (NYHA class ≥2) identify a high-risk cohort for subsequent death or heart failure hospitalization in STEMI patients treated with primary PCI, independent of infarct size.
Answers are grounded in this paper and cite their sources.
Early post-discharge NYHA ≥2 symptoms flag high-risk STEMI patients after PCI; hypothesis-generating for targeted intervention trials.
BACKGROUND: The determinants and significance of early (30-day) heart failure symptoms after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (STEMI) remain unclear. We investigated the clinical and imaging correlates of early post-discharge heart failure in patients with STEMI, and evaluated its impact on clinical outcomes. METHODS: Patients from the INFUSE-AMI trial were categorized according to New York Heart Association (NYHA) functional classification at their 30-day visit (NYHA class ≥2 versus 1). Independent correlates of NYHA class ≥2 were determined by multivariable logistic regression. A landmark analysis beyond 30 days was performed to assess the impact of 30-day NYHA class ≥2 on 1-year risk of death or hospitalization for heart failure. RESULTS: Among 402 patients enrolled in the INFUSE-AMI trial with data on NYHA class at 30 days, 76 (18.9%) had NYHA class ≥2. Independent correlates of 30-day NYHA class ≥2 were age, Killip class ≥2 at presentation, heart rate at presentation, intraprocedural no-reflow, and 30-day infarct size (% total ventricular mass). After adjustment for infarct size, patients with NYHA class ≥2 remained at higher risk of death or hospitalization for heart failure at 1-year follow-up compared to those in NYHA class 1 (11.8% vs. 2.8%, adjusted hazard ratio 3.78, 95% confidence interval 1.16-12.22, P=0.03). CONCLUSIONS: Clinical, procedural, and imaging variables predict the development of clinical heart failure after primary percutaneous coronary intervention in patients with STEMI. Early post-discharge heart failure symptoms identify a high-risk patient cohort for subsequent heart failure hospitalization and death, independent of infarct size. TRIAL REGISTRATION: ClinicalTrials.gov ; NCT00976521.
No takes yet. Share an insight, caveat, or question.
Giustino et al. (2017) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=402). NYHA class ≥2 at 30 days vs. NYHA class 1 at 30 days was evaluated on death or hospitalization for heart failure (HR 3.78, 95% CI 1.16-12.22, p=0.03). Early post-discharge heart failure symptoms (functional class ≥2) after STEMI were associated with a higher 1-year risk of death or heart failure hospitalization.
Synapse has enriched 10 related papers. Consider them for comparative context: